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Pulp and paper production workers have been
exposed to a complex mixture of hazardous
substances, including known or suspected car-
cinogens such as wood dust, various wood
extracts and associated bioaerosols, reduced
sulfur compounds, talc, formaldehyde, com-
bustion products, epichlorohydrin, acid mists,
auramine and other benzidine-based dyes, and
a range of chlorinated organic compounds
(Kauppinen et al. 1997, 2002). The patterns
of exposure in the industry are complicated
because of the range of different processes that
have been used over time in the various stages
of pulp and paper manufacture, which
together with the relatively small numbers of
workers within speciﬁc departments has lim-
ited the power of epidemiologic studies of
mill-based cohorts. A number of studies, nev-
ertheless, have suggested increased risks of
gastrointestinal cancers (Henneberger et al.
1989; Milham and Demers 1984), respiratory
system cancers (Milham and Demers 1984;
Siemiatycki et al. 1986; Toren et al. 1991),
and certain lymphatic and hematopoietic neo-
plasms (Coggon et al. 1997; Matanoski et al.
1998) in pulp and paper industry workers.
Despite the large number of studies con-
ducted, there is still uncertainty about the
exact nature and extent of cancer risks associ-
ated with work in this industry (Toren 1996).
The International Agency for Research on
Cancer (IARC) therefore coordinated an
international collaborative cohort study to
investigate mortality and cancer incidence in
the pulp, paper, paperboard, recycled paper,
and paper product industries. This study has
combined cohorts from 13 countries, consist-
ing of 98,665 workers (2,110,913 person-
years), and included the development of a
comprehensive database of exposure measure-
ments for the retrospective assessment of
study participants’ exposure (Kauppinen et al.
1997, 2002). The results for mortality and
incidence in selected national cohorts (Fassa
et al. 1998; Henneberger and Lax 1998;
Henneberger et al. 1989; Jäppinen and
Pukkala 1991; Jäppinen and Tola 1986;
Langseth and Andersen 1999, 2000; McLean
et al. 2002; Rix et al. 1997, 1998; Sala-Serra
et al. 1996; Szadkowska-Stanczyk et al. 1997;
Szadkowska-Stanczyk and Szymczak 2001;
Wild et al. 1998), and for separate analyses of
exposure to sulfur dioxide (Lee et al. 2002)
and asbestos (Carel et al. 2002) in the overall
cohort, have been reported.
Workers in this industry experience expo-
sure to chlorinated organic compounds, both
volatile chlorinated hydrocarbons such as
trichloroethylene, perchloroethylene, dichloro-
methane, and trichloromethane, and non-
volatile organochlorine compounds such as
chlorophenols and their salts [pentachloro-
phenol (PCP)], polychlorinated biphenyls
(PCBs), and polychlorinated dibenzodioxins
(PCDDs) or polychlorinated dibenzofurans
(PCDFs). IARC has classified the volatile
organochlorines trichloroethylene and per-
chloroethylene as probably carcinogenic to
humans (group 2A) on the basis of limited evi-
dence in humans of excess risks of cancer of
the liver and biliary tract, non-Hodgkin lym-
phoma (NHL), and esophageal and cervical
cancer, and dichloromethane and trichloro-
methane as possibly carcinogenic to humans
(group 2B) based on sufficient evidence for
carcinogenicity in animals (Siemiatycki et al.
2004). Of the nonvolatile organochlorine
compounds, IARC has classiﬁed the 2,3,7,8-
substituted tetrachlorodibenzo-para-dioxins
(TCDDs) as carcinogenic to humans (group 1)
on the basis of both mechanistic evidence and
limited evidence in humans of excess risk of all
cancers combined rather than for any speciﬁc
site cancer; PCBs as probably carcinogenic to
humans (group 2A) because of limited evidence
of excess cancers of the liver and biliary tract
and of lymphatic and hematopoietic tissues;
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The objective of this study was to evaluate cancer mortality in pulp and paper industry workers
exposed to chlorinated organic compounds. We assembled a multinational cohort of workers
employed between 1920 and 1996 in 11 countries. Exposure to both volatile and nonvolatile
organochlorine compounds was estimated at the department level using an exposure matrix. We
conducted a standardized mortality ratio (SMR) analysis based on age and calendar-period–specific
national mortality rates and a Poisson regression analysis. The study population consisted of
60,468 workers. Workers exposed to volatile organochlorines experienced a deficit of all-cause
[SMR = 0.91; 95% confidence interval (CI), 0.89–0.93] and all-cancer (SMR = 0.93; 95% CI,
0.89–0.97) mortality, with no evidence of increased risks for any cancer of a priori interest. There
was a weak, but statistically significant, trend of increasing risk of all-cancer mortality with increas-
ing weighted cumulative exposure. A similar deficit in all-cause (SMR = 0.94; 95% CI, 0.91–0.96)
and all-cancer (SMR = 0.94; 95% CI, 0.89–1.00) mortality was observed in those exposed to non-
volatile organochlorines. No excess risk was observed in cancers of a priori interest, although mor-
tality from Hodgkin disease was elevated (SMR = 1.76; 95% CI, 1.02–2.82). In this study we found
little evidence that exposure to organochlorines at the levels experienced in the pulp and paper
industry is associated with an increased risk of cancer, apart from a weak but significant association
between all-cancer mortality and weighted cumulative volatile organochlorine exposure. Key words:
epidemiology, mortality, neoplasms, organochlorines, pulp and paper industry. Environ Health
Perspect 114:1007–1012 (2006). doi:10.1289/ehp.8588 available via http://dx.doi.org/ [Online
13 March 2006]
and PCPs and their sodium salts as possibly
carcinogenic to humans (group 2B) based on
findings of excess risk of soft tissue sarcoma
and NHL (Siemiatycki et al. 2004). The aim
of the present study was to investigate the asso-
ciation between cancer mortality and exposure
to chlorinated organic compounds in the
IARC pulp and paper workers cohort.
Materials and Methods
Workers employed for at least 1 year in the
pulp and paper industry in 13 countries during
the period 1920–1996 were included in the
overall IARC study, with cohorts from
Denmark, Finland, France, Japan, New
Zealand, Norway, Poland, Spain, Sweden,
Scotland, and the United States included in
this analysis of organochlorine exposure. Brazil
and South Africa were excluded from this
analysis because of inadequacies in the quality
of mortality data. Cohort members were iden-
tiﬁed from company personnel records, with
work histories available for the full period of
employment in that company.
The exposure assessment procedure used
for this study has been described in detail else-
where (Kauppinen et al. 1997, 2002). Brieﬂy,
an international panel of industrial hygiene
experts used their professional judgment to
estimate exposure over different time periods
to 27 main agents at the level of department
(but not speciﬁc job titles within departments)
in each of the mills studied, based on detailed
company questionnaires on current and his-
torical raw materials and production processes,
and < 31,000 existing (mainly unpublished)
occupational exposure measurements. Where
sufficient measurement data were available,
the expected prevalence and level of exposure
to specific agents were quantified, and then
depending on the range of estimated exposure
levels for each agent, limits for low-, medium-,
and high-exposure categories were assigned.
For these agents, each worker’s weighted
cumulative exposure was then estimated by
combining the prevalence, level, and duration
of exposure. Where only limited measurement
data were available, a qualitative assessment of
likely, unlikely, or unknown potential for
exposure was made.
Exposure to volatile organochlorine com-
pounds was deﬁned as inhalatory exposure to
chlorinated solvents or other specified com-
pounds (indicator agents being trichloro-
ethylene, perchloroethylene, dichloromethane,
and trichloromethane) at a level exceeding the
nonoccupational background level. These sub-
stances have been used as cleaning and
degreasing agents in most departments, with
the highest exposures occurring in mainte-
nance, repair, and cleaning operations, and
medium exposures in sulfate pulp and pulp
bleaching departments. The high-exposure
category was defined as workers in those
departments in which > 50% were exposed
and in which the mean level of exposure over
the work year was estimated to exceed 1 ppm
for trichloromethane, 2.5 ppm for perchloro-
ethylene, and 5 ppm for dichloromethane and
trichloroethylene [all 1/10th of the threshold
limit value of the American Conference of
Governmental Industrial Hygienists (ACGIH
2005)].
Nonvolatile organochlorine exposure was
assessed in qualitative terms as ever/never
exposed, with exposure defined as potential
dermal or inhalatory exposure to PCP or its
salts, PCBs, PCDDs, PCDFs, or other non-
volatile organochlorine compounds exceeding
the nonoccupational long-term background
level. PCP has been used to prevent sapstain
in softwoods used for pulp, with consequent
worker exposure during pulping operations.
Exposure to PCBs is most likely to have
occurred during maintenance and repair of
electrical or hydraulic equipment. Both PCP
and PCBs contain PCDDs and PCDFs as
contaminants of their manufacture, and
PCDDs and PCDFs may also be formed as
by-products of the bleaching of pulp with
chlorine compounds, resulting in occupational
exposure both during bleaching and down-
stream for those involved in paper production
(Krishnan 1990).
Workers were followed up for mortality
according to procedures speciﬁc to each coun-
try. The period of follow-up varied among
countries, ranging from 12 to 50 years. Details
on periods of employment and follow-up are
reported in Table 1. Causes of death were
either abstracted from death certificates or
obtained from mortality registries, and coded
according to the International Classification of
Diseases, 9th Revision (ICD-9) [World Health
Organization (WHO) 1975]. Tabulation of
person-years started at the beginning of the
observation period or on day 1 of the second
year of employment if this occurred after the
start of the observation period. Standardized
mortality ratios (SMRs) were calculated as the
ratio of observed to expected deaths, with
expected deaths being computed by multiply-
ing the person-years in each sex-speciﬁc, age-
specific, and 5-year calendar-period–specific
stratum by the national reference rates using
the Person Years program (Coleman et al.
1986). National rates were derived from the
WHO Mortality Database (WHO 2001).
Ninety-ﬁve percent conﬁdence intervals (CIs)
of the SMR were calculated under the assump-
tion that the observed numbers of deaths fol-
low a Poisson distribution. Internal analyses
were conducted according to years since ﬁrst
employment (< 18, 18–27, 28–37, > 38 years)
and duration of exposure (< 4, 4–10, 11–21,
> 22 years), and for the volatile organochlo-
rines also by cumulative exposure (Σ level ×
duration; < 3, 3–9, 10–29, > 30 ppm-years)
and weighted cumulative exposure (Σ preva-
lence × level × duration: < 1, 1–17, > 18 ppm-
years), with cut points for continuous
measurements of exposure set at quartiles or
tertiles depending on numbers available. Tests
for linear trend in SMRs were performed
using a method described by Breslow and Day
(1987).
Poisson regression analysis was used to
examine internal dose–response relations asso-
ciated with exposure to volatile organochlo-
rines and to explore the effect of potential
confounding factors. Rate ratios (RRs) and
McLean et al.
1008 VOLUME 114 | NUMBER 7 | July 2006 • Environmental Health Perspectives
Table 1. Distribution of study participants by exposure status and country.
Volatile organochlorines Nonvolatile organochlorines
Employment Follow-up Never exposeda Ever exposeda High exposureb Never exposeda Ever exposeda
Country period period No. Person-years No. Person-years No. Person-years No. Person-years No. Person-years
Denmark 1920–1992 1943–1993 1,512 27,258 5,762 142,519 2,538 64,274 2,863 61,791 4,813 115,777
Finland 1935–1995 1945–1995 927 28,048 6,964 218,387 653 13,664 4,022 124,524 3,180 97,437
France 1921–1992 1968–1992 386 6,009 3,260 60,402 36 764 2,265 37,902 2,119 40,811
Japan 1946–1996 1976–1996 567 9,880 1,602 29,520 129 2,609 1,097 19,843 1,221 22,396
New Zealand 1955–1992 1980–1992 3,396 34,792 2,583 27,702 1,155 12,388 4,635 47,717 1,067 11,973
Norway 1920–1993 1953–1993 2,386 55,430 16,002 420,322 4,491 120,494 9,942 252,707 6,063 150,908
Poland 1967–1990 1968–1990 3,538 50,850 2,399 37,676 159 2,902 4,252 61,350 1,833 29,421
Scotland 1920–1990 1955–1994 525 12,480 3,534 85,965 26 810 414 7,075 604 11,171
Spain 1955–1991 1970–1992 228 3,946 1,199 21,219 8 80 2,379 48,815 1,729 33,830
Sweden 1920–1990 1955–1991 969 17,329 2,475 53,210 379 8,323 728 16,947 2,151 53,250
United States 1920–1982 1961–1991 147 2,824 107 2,014 54 1,127 625 10,973 160 3,162
Total 14,581 248,846 45,887 1,098,936 9,628 229,434 33,222 689,645 24,940 570,135
aThe total number of workers that could be classified by exposure to volatile (60,468) and nonvolatile (58,162) organochlorines differed. bHigh exposure is a subset of ever exposure.
95% CIs derived from the analysis were
adjusted for country, sex, age, calendar
period, and employment status (i.e., whether
person-years accumulated while workers were
employed in the companies included in the
study). The reference group for each RR was
the ﬁrst level of each variable.
Results
The distribution of study participants by
exposure status and country is shown in
Table 1. At the end of follow-up of the over-
all cohort, 79% of the workers were alive,
18% had died, 2% were lost to follow-up,
and 1% had emigrated. Altogether, 60,468
workers (1,347,782 person-years) were classi-
fied according to volatile organochlorine
exposure status, with 82% of the person-years
classified as ever exposed and 17% (i.e.,
9,628 workers or 229,434 person-years) as
having high exposure. A total of 58,162
workers (1,259,780 person-years) were classi-
fied according to nonvolatile organochlorine
exposure status, with 45% (i.e., 24,940 work-
ers or 570,135 person-years) classiﬁed as ever
exposed. There was significant overlap
between the two exposure groups, with main-
tenance workers in particular often experienc-
ing exposure to both volatile and nonvolatile
organochlorines.
Cause-specific mortality for the workers
classified according to exposure to volatile
organochlorines is shown in Table 2. Among
exposed workers there was a deficit of all
causes of death (9,350 deaths; SMR = 0.91;
95% CI, 0.89–0.93) and of all malignant
neoplasms (2,285 deaths; SMR = 0.93; 95%
CI, 0.89–0.97). Of the cancers of a priori
interest, there were reduced SMRs for cancer
of the esophagus (45 deaths; SMR = 0.74;
95% CI, 0.54–0.99), liver (33 deaths;
SMR = 0.76; 95% CI, 0.53–1.07), and cervix
(17 deaths; SMR = 0.99; 95% CI, 0.58–1.59);
for neoplasms of lymphatic or hematopoietic
tissues (189 deaths; SMR = 0.94; 95% CI,
0.81–1.08); and for NHL (52 deaths;
SMR = 0.86; 95% CI, 0.64–1.13). Statistically
signiﬁcant excess mortality from pleural neo-
plasms was observed in the exposed group
(20 deaths; SMR = 2.00; 95% CI, 1.22–3.09),
mostly due to the even larger excess observed
in the highly exposed subjects (8 deaths;
SMR = 3.67; 95% CI, 1.58–7.23) who were
maintenance workers also exposed to asbestos.
The elevation observed in those never exposed
was virtually identical (4 deaths; SMR = 1.91;
95% CI, 0.52–4.90) to the exposed group,
possibly also due to asbestos exposure. Other
statistically signiﬁcant ﬁndings included excess
mortality from cancer of the penis and other
male genital organs (7 deaths; SMR = 2.51;
95% CI, 1.01–5.17) in the exposed group, and
cancer of other respiratory organs (4 deaths;
SMR = 3.84; 95% CI, 1.05–9.84) in the
highly exposed group. The results reported
here are for the overall cohort including both
men and women. In general, there was little
difference in the findings between sexes,
although the results among women were based
on a relatively small number of deaths.
Cause-specific mortality for the workers
classiﬁed according to exposure to nonvolatile
organochlorines is shown in Table 3. All-cause
mortality in the exposed workers was below
expected (4,622 deaths; SMR = 0.94; 95%
CI, 0.91–0.96), as was mortality from all can-
cer (1,145 deaths; SMR = 0.94; 95% CI,
0.89–1.00). Mortality from the other neo-
plasms of a priori interest was also below
expected, including liver cancer (16 deaths;
SMR = 0.69; 95% CI, 0.40–1.13), soft tissue
sarcoma (4 deaths; SMR = 0.80; 95% CI,
0.22–2.04), lymphatic and hematopoietic tis-
sue neoplasms in general (97 deaths;
SMR = 0.99; 95% CI, 0.81–1.21), and NHL
in particular (25 deaths; SMR = 0.86; 95%
CI, 0.55–1.26). The only neoplasms showing
elevated risks were penis and other cancer of
male genital organs (5 deaths; SMR = 3.60;
95% CI, 1.17–8.40) and Hodgkin disease
Organochlorine exposure and cancer mortality
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Table 2. SMRs for selected causes by exposure to volatile organochlorine compounds.
Never exposed Ever exposed High exposurea
Cause of death (ICD-9 codes) Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
All causes 2,175 0.88 0.84–0.91 9,350 0.91 0.89–0.93 1,902 0.90 0.86–0.95
All neoplasms (140–208) 524 0.91 0.83–0.99 2,285 0.93 0.89–0.97 517 1.01 0.93–1.10
Oral cavity and pharynx (140–149) 9 0.68 0.31–1.29 33 0.61 0.42–0.86 11 1.09 0.54–1.95
Esophagus (150) 15 0.99 0.56–1.64 45 0.74 0.54–0.99 6 0.57 0.21–1.24
Stomach (151) 60 0.98 0.75–1.26 201 0.83 0.72–0.95 43 0.95 0.69–1.28
Colon (153) 38 0.98 0.69–1.34 140 0.85 0.72–1.01 35 0.90 0.63–1.25
Rectum (154) 18 0.68 0.40–1.07 98 0.91 0.74–1.10 30 1.19 0.80–1.70
Liver (155) 10 0.76 0.37–1.41 33 0.76 0.53–1.07 6 0.83 0.31–1.82
Gallbladder (156) 6 1.24 0.45–2.69 14 0.66 0.36–1.10 4 1.05 0.29–2.70
Pancreas (157) 32 1.07 0.74–1.52 115 0.90 0.75–1.09 19 0.71 0.42–1.10
Larynx (161) 9 1.18 0.54–2.24 29 1.00 0.67–1.43 3 0.65 0.13–1.89
Lung (162) 122 0.85 0.70–1.01 613 1.04 0.96–1.13 125 1.06 0.88–1.26
Pleura (163) 4 1.91 0.52–4.90 20 2.00 1.22–3.09 8 3.67 1.58–7.23
Other respiratory (164–165) 0 0.00 0.00–2.74 10 1.72 0.82–3.15 4 3.84 1.05–9.84
Soft tissue (171) 2 0.88 0.11–3.20 12 1.13 0.59–1.98 4 1.75 0.48–4.48
Melanoma (172) 9 1.02 0.47–1.94 42 1.12 0.81–1.51 6 0.63 0.23–1.37
Breast (174–175) 4 0.94 0.26–2.41 63 0.96 0.73–1.22 6 0.61 0.22–1.32
Cervix uteri (180) 1 0.89 0.02–4.98 17 0.99 0.58–1.59 2 0.67 0.08–2.40
Prostate (185) 44 0.79 0.58–1.07 177 0.86 0.74–1.00 49 1.02 0.76–1.35
Penis and other male genital organs (187) 1 1.46 0.04–8.11 7 2.51 1.01–5.17 2 3.11 0.38–11.2
Bladder (188) 17 0.88 0.51–1.40 87 1.09 0.88–1.35 20 1.07 0.65–1.65
Kidney (189) 12 0.77 0.40–1.34 54 0.77 0.58–1.01 15 0.97 0.54–1.59
Brain (191–192) 16 1.02 0.58–1.66 68 0.98 0.76–1.25 20 1.25 0.76–1.93
Lymphatic and hematopoietic (200–208) 45 0.96 0.70–1.28 189 0.94 0.81–1.08 41 0.92 0.66–1.25
NHL (200, 202) 15 1.12 0.63–1.86 52 0.86 0.64–1.13 11 0.84 0.42–1.51
Hodgkin disease (201) 4 0.94 0.26–2.42 21 1.07 0.66–1.63 4 0.93 0.25–2.39
Multiple myeloma (203) 7 0.76 0.31–1.58 41 1.02 0.73–1.38 9 1.00 0.46–1.90
Leukemia (204–208) 19 0.99 0.60–1.55 75 0.93 0.73–1.17 17 0.95 0.55–1.51
Circulatory system diseases (390–459) 1,042 0.91 0.86–0.97 4,444 0.95 0.92–0.98 877 0.92 0.86–0.98
Respiratory system diseases (460–519) 130 0.77 0.64–0.91 561 0.82 0.75–0.89 97 0.72 0.59–0.88
Digestive system diseases (520–579) 60 0.71 0.54–0.91 299 0.85 0.75–0.95 47 0.68 0.50–0.91
Liver cirrhosis (571) 23 0.77 0.49–1.16 119 0.95 0.79–1.14 24 1.00 0.64–1.48
Obs, observed. 
aHigh exposure is a subset of ever exposure.
(17 deaths; SMR = 1.76; 95% CI, 1.02–2.82),
and in both sites this was more than three
times the rate observed in the workers never
exposed. It is of interest to note, however, that
the 3-fold excesses in risk of cancer of the
penis and other male genital organs and of
Hodgkin disease in workers not exposed to
nonvolatile organochlorines are matched by
deficits (of a similar magnitude) in risk of
pleural and other respiratory cancers in those
not exposed.
No consistent pattern of increasing risk
with increasing exposure to either volatile or
nonvolatile organochlorines was apparent for
any cause of death after stratiﬁcation by dura-
tion of employment or by years since first
exposure to both volatile and nonvolatile com-
pounds, or by weighted cumulative exposure
to volatile organochlorines (data not shown).
The Poisson regression analyses stratified
according to weighted cumulative volatile
organochlorine exposure (shown in Table 4),
and adjusted for sex, age, employment status,
calendar year, and country, showed a weak
(p = 0.002) trend of increasing risk of mortal-
ity from all cancer combined with increasing
weighted cumulative exposure to volatile
organochlorines (< 1 ppm-years: RR = 1;
1–17 ppm-years: RR = 1.12; 95% CI,
1.01–1.24; > 18 ppm-years: RR = 1.19; 95%
CI, 1.016–1.34). No other site of a priori
interest showed a statistically signiﬁcant trend
of increasing risk, although nonsignificant
increases were suggested for liver cancer and
for cancer of the pleura. The risk estimates,
and the positive trend, for cancer of the pleura
were essentially unchanged after adjustment
for either exposure to or high exposure to
asbestos.
Discussion
In this large multicenter historical cohort
study, which examined the risks associated
with exposure to both volatile and nonvolatile
organochlorines in the pulp and paper industry
work environment, we found lower than
expected overall mortality and all-cancer mor-
tality rates. Internal comparisons based on
duration of exposure and time since ﬁrst expo-
sure showed no consistent exposure–response
trends of risk increasing with either volatile or
nonvolatile organochlorines. A weak, but sta-
tistically signiﬁcant, trend of increasing risk of
all-cancer mortality with increasing weighted
cumulative exposure to volatile organochlo-
rines was observed. This ﬁnding is similar to
the effect seen in other large cohorts with
potential exposure to nonvolatile organochlo-
rines contaminated with TCDD (Kogevinas
et al. 1997) but has not previously been
reported for volatile organochlorine exposure.
As in most historical cohort studies of
industrial workers, we found a deﬁcit in overall
mortality and cancer mortality in this study
compared with rates expected in the national
populations. This is common in occupational
cohort mortality studies and has been observed
in previous studies of pulp and paper work-
ers (Band et al. 2001; Coggon et al. 1997;
Matanoski et al. 1998), due to the healthy
worker effect that arises because healthy people
are more likely to gain employment and to
remain in employment (Checkoway et al.
2004). The healthy worker effect is generally
weaker for cancer than for other causes of
mortality, as observed in this study.
The assessment of exposure was based on a
pulp and paper industry exposure matrix
developed by an expert team of industrial
hygienists familiar with the pulp and paper
industry, although relatively few quantitative
data were available on organochlorine exposure
(Kauppinen 1997). Estimates of organochlo-
rine exposure were therefore based largely on
information available from company question-
naires about processes and raw materials used
(e.g., time periods when chlorine bleaching was
done or when PCBs were used in mill electrical
equipment). Work histories were available only
at the department level for most of the mills
under study, so individual exposure estimates
were based on the level and prevalence of expo-
sure in the department worked in rather than
on a more specific job title. The inability to
take into account heterogeneity of exposure
among workers in a department is likely to
have resulted in signiﬁcant nondifferential mis-
classification of exposure, resulting in a ten-
dency to underestimate any true elevation of
risk associated with exposure. In addition,
McLean et al.
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Table 3. SMRs for selected causes by exposure to nonvolatile organochlorine compounds.
Never exposed Ever exposed
Cause of death (ICD-9 codes) Obs SMR 95% CI Obs SMR 95% CI
All causes 5,771 0.89 0.87–0.91 4,622 0.94 0.91–0.96
All neoplasms (140–208) 1,434 0.94 0.89–0.99 1,145 0.94 0.89–1.00
Oral cavity and pharynx (140–149) 33 0.92 0.63–1.29 15 0.51 0.29–0.85
Esophagus (150) 27 0.71 0.41–1.03 26 0.78 0.51–1.15
Stomach (151) 146 0.93 0.79–1.10 98 0.89 0.72–1.08
Colon (153) 106 1.04 0.85–1.25 62 0.74 0.57–0.95
Rectum (154) 60 0.87 0.66–1.12 51 0.96 0.71–1.26
Liver (155) 27 0.87 0.57–1.27 16 0.69 0.40–1.13
Pancreas (157) 67 0.84 0.65–1.06 69 1.12 0.87–1.42
Larynx (161) 18 0.92 0.54–1.45 20 1.23 0.75–1.90
Lung (162) 356 0.98 0.88–1.08 314 1.04 0.93–1.17
Pleura (163) 17 2.78 1.62–4.45 4 0.78 0.21–2.01
Other respiratory (164–165) 8 2.11 0.91–4.16 2 0.66 0.08–2.39
Soft tissue (171) 8 1.22 0.53–2.41 4 0.80 0.22–2.04
Melanoma (172) 20 0.82 0.50–1.27 21 1.17 0.72–1.78
Breast (174–175) 21 0.90 0.55–1.37 32 0.89 0.61–1.25
Prostate (185) 117 0.85 0.70–1.02 84 0.93 0.74–1.15
Penis and other male genital organs (187) 2 1.12 0.14–4.05 5 3.60 1.17–8.40
Bladder (188) 50 1.00 0.74–1.32 43 1.09 0.79–1.46
Kidney (189) 41 0.94 0.67–1.27 18 0.53 0.31–0.83
Brain (191–192) 44 1.02 0.74–1.37 28 0.80 0.53–1.15
Lymphatic and hematopoietic (200–208) 112 0.88 0.72–1.05 97 0.99 0.81–1.21
NHL (200, 202) 35 0.93 0.65–1.30 25 0.86 0.55–1.26
Hodgkin disease (201) 7 0.58 0.23–1.19 17 1.76 1.02–2.82
Multiple myeloma (203) 21 0.83 0.51–1.27 20 1.07 0.66–1.66
Leukemia (204–208) 49 0.95 0.70–1.26 35 0.89 0.62–1.24
Circulatory system diseases (390–459) 2,727 0.92 0.89–0.96 2,157 0.99 0.95–1.04
Respiratory system diseases (460–519) 327 0.78 0.69–0.86 266 0.82 0.72–0.92
Digestive system diseases (520–579) 167 0.74 0.63–0.86 166 0.91 0.77–1.05
Obs, observed.
Table 4. Mortality from selected causes by weighted cumulative exposure to volatile organochlorines.
Weighted cumulative exposure to volatile organochlorinesa
< 1 ppm-yearsb 1–17 ppm-years > 18 ppm-years
Cause of death (ICD-9 codes) Obs RRc Obs RR 95% CI Obs RR 95% CI Trendd
All neoplasms (140–208) 1,006 1 778 1.12 (1.01–1.24) 489 1.19 (1.06–1.34) 0.002
Esophagus (150) 26 1 14 0.94 (0.46–1.90) 5 0.54 (0.19–1.51) 0.289
Liver (155) 18 1 9 1.05 (0.42–2.65) 6 1.45 (0.51–4.16) 0.525
Lung (162) 253 1 236 1.15 (0.95–1.39) 120 1.07 (0.85–1.36) 0.394
Pleura (163) 6 1 6 1.16 (0.36–3.78) 8 2.49 (0.83–7.53) 0.114
Lymphatic and hematopoietic 90 1 66 1.09 (0.78–1.54) 33 0.93 (0.61–1.42) 0.859
(200–208)
NHL (200, 202) 25 1 18 1.15 (0.60–2.22) 9 0.97 (0.43–2.20) 0.955
Obs, observed. 
aWeighted cumulative exposure (Σ prevalence × level × duration). bReference category. cRR adjusted for sex, age,
employment status, calendar year, and country. dp-Value of test for linear trend.
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because the exposure assessment for the non-
volatile organochlorines was qualitative, it was
possible only to make internal comparisons
based on the likelihood of ever being exposed
rather than evaluating trends according to
cumulative dose.
As with most historical cohort studies,
there is also a lack of information on poten-
tial lifestyle confounders such as smoking.
However, even for lung cancer, the relatively
small differences in smoking status between
groups of manual workers are unlikely to
account for a relative risk of > 1.5 in studies
involving a comparison with national mortal-
ity rates (Axelson 1978), and the confounding
effect is even weaker for internal dose–
response analyses (Siemiatycki et al. 1988). It
is therefore unlikely that there is serious con-
founding by lifestyle factors in the present
study, even regarding the ﬁndings for pleural
cancer and other respiratory cancers. It is pos-
sible that the weak but statistically signiﬁcant
exposure–response relationship for all cancers
associated with weighted cumulative exposure
to volatile compounds could be due to con-
founding by lifestyle factors or to the expo-
sure of many maintenance workers to other
carcinogens, including asbestos.
Overall, we found little evidence of any
increased risk of cancer mortality in pulp and
paper workers exposed to organochlorines,
apart from the weak but statistically signiﬁcant
exposure–response trend for cumulative expo-
sure to volatile organochlorines. Although
there is evidence of such an association for all
cancers with exposure to phenoxy herbicides
contaminated with TCDD (Kogevinas et al.
1997), we are not aware of any evidence sug-
gesting such an association for volatile
organochlorine exposure of the type that
occurs in pulp and paper mills. Although sta-
tistically signiﬁcant, the association was rela-
tively weak, and this ﬁnding should therefore
be regarded as preliminary and requiring fur-
ther investigation.
We found little evidence of increased risks
for speciﬁc cancer sites that have been previ-
ously associated with organochlorine expo-
sure, including cancer of the esophagus, liver,
cervix, and NHL for volatile organochlorines,
and cancer of the liver, soft tissue sarcoma,
lymphatic, and hematopoietic tissue and
NHL for nonvolatile organochlorines.
Instead, the only sites that showed signiﬁcant
excess risks in those exposed to volatile
organochlorines were cancer of the pleura,
“other respiratory,” and “penis and other
male genital organs,” and for all three sites the
risk was higher in those with high exposure.
Interestingly, although the excess risk for can-
cer of penis and other male genital organs was
also elevated in those with exposure to non-
volatile organochlorines, the risks for cancer
of the pleura and other respiratory cancers
were elevated only in those never exposed to
nonvolatile organochlorines and below
expected in those with exposure. For pleural
cancer, this may be because many of the
group classified as exposed to nonvolatile
organochlorines were bleach plant operators,
whereas the group with volatile organochlo-
rine exposure were predominantly mainte-
nance workers. So it is possible that these
findings could be due to concomitant expo-
sure to asbestos, because the highest exposures
to these compounds occurred in maintenance,
repair, and cleaning operations, and an excess
risk of pleural cancer has already been reported
in workers exposed to asbestos in this industry
(Carel et al. 2002). Unfortunately, joint
analyses of asbestos and organochlorine expo-
sure were equivocal because most of the
pleural and other respiratory cancers occurred
in workers exposed to both factors, and there
were insufficient numbers to determine
whether there were increased risks in workers
exposed to nonvolatile organochlorines alone.
When the organochlorine findings were
adjusted for asbestos exposure (data not
shown), the RRs were essentially unchanged.
Although the elevated risk observed for both
cancers of penis and other male genital organs
and other respiratory cancers was statistically
significant, in both cases the CIs were wide
and the small number of cases precluded fur-
ther analysis. It is possible, therefore, that
these are chance findings. Increased risks of
Hodgkin disease, however, have been consis-
tently reported among pulp mill workers
(Milham and Demers 1984; Toren et al.
1996), woodworkers (McCunney 1999), and
those with exposure to the herbicides 2,4-D
(2,4-dichlorophenoxyacetic acid), 2,4,5-T
(2,4,5-trichlorophenoxyacetic acid) and its
contaminant TCDD, cacodylic acid, and
picloram (Dich et al. 1997; Institute of
Medicine 2000). The statistically significant
increase in risk observed among workers with
exposure to nonvolatile organochlorines in
this cohort appears to be consistent with these
earlier ﬁndings. Because the survival for NHL
is relatively good, an analysis of incidence
would have been more informative, but unfor-
tunately cancer incidence data were available
only from Denmark, Finland, New Zealand,
Norway, and Sweden. The lack of incidence
data and the small number of cases precluded
any further analysis of this association.
In summary, there is little evidence that
exposure to organochlorines at the levels expe-
rienced in the pulp and paper industry causes
an increased risk of cancer, apart from a
weakly statistically signiﬁcant association with
weighted cumulative volatile organochlorine
exposure. There was little evidence of an
increased risk for any specific cancer sites,
apart from a statistically signiﬁcant association
between nonvolatile organochlorine exposure
and Hodgkin disease and cancer of the pleura.
The finding for pleural cancer is consistent
with evidence that maintenance workers were
exposed to asbestos.
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